| Literature DB >> 28851782 |
Celia P Grigg1, Sally K Tracy2, Mark Tracy2, Rea Daellenbach3, Mary Kensington3, Amy Monk4, Virginia Schmied5.
Abstract
OBJECTIVE: To compare maternal and neonatal birth outcomes and morbidities associated with the intention to give birth in a freestanding primary level midwife-led maternity unit (PMU) or tertiary level obstetric-led maternity hospital (TMH) in Canterbury, Aotearoa/New Zealand.Entities:
Keywords: New Zealand; clinical outcomes; freestanding; midwife-led; primary maternity unit; tertiary hospital
Mesh:
Year: 2017 PMID: 28851782 PMCID: PMC5634452 DOI: 10.1136/bmjopen-2017-016288
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Flow chart of EMU study recruitment, inclusions and exclusions. EMU, Evaluate primary freestanding midwife-led Maternity Units; PMU, primary level midwife-led maternity unit; TMH, tertiary level obstetric-led maternity hospital.
Participants’ demographics by planned birthplace
| Characteristics | Primary (PMU) | Tertiary (TMH) | p Value |
| Mean age | 30.8 | 32.1 | 0.001 |
| <25 | 56 (13.8) | 26 (9.2) | 0.01 |
| 25–29 years | 127 (31.2) | 67 (23.6) | |
| 30–34 years | 142 (34.9) | 120 (42.3) | |
| ≥35 years | 83 (20.2) | 71 (25) | |
| Median (mean) parity | 1 (0.9) | 0 (0.5) | <0.0001 |
| Proportion of nulliparous women | 167 (41.0%) | 157 (54.1%) | <0.0001 |
| Ethnicity | |||
| NZ European | 308 (75.7%) | 226 (79.3%) | |
| Māori | 30 (7.4%) | 6 (2.1%) | <0.009 |
| Other | 69 (17.0%) | 53 (18.6%) | |
| Smoker | 31 (7.6%) | 15 (5.3%) | NS |
| Residence | |||
| City or semirural | 308 (75.7%) | 248 (87.0%) | <0.0001 |
| Rural or remote rural | 99 (25.3%) | 37 (13.0%) | |
| Has a partner | 377 (92.4%) | 260 (91.6%) | |
| BMI | |||
| <25 | 233 (58.7%) | 196 (69.3%) | |
| 25–35 | 149 (37.5%) | 79 (27.9%) | 0.02 |
| >35 | 15 (3.8%) | 8 (2.8%) | |
| Income* | (n=326), no (%) | (n=226), no (%) | |
| <NZ$25 000 per annum before tax | 20 (6.1%) | 14 (6.2%) | |
| $25 000 to $50 000 | 95 (29.1%) | 34 (15.0%) | 0.001 |
| $50 000 to $75 000 | 99 (30.4%) | 70 (31.0%) | |
| >NZ$75 000 | 112 (34.4%) | 108 (47.8%) | |
| Education* | (n=331), no (%) | (n=230), no (%) | |
| No postschool completed | 67 (20.2%) | 36 (15.7%) | |
| Apprenticeship, certificate | 55 (16.6%) | 32 (13.9%) | NS |
| Diploma | 56 (16.9%) | 41 (17.8%) | |
| Degree | 153 (46.2%) | 121 (52.6%) |
*Different denominator—survey response data, not full study cohorts (82%).
BMI, body mass index; NS, not significant;
Maternal clinical outcomes by planned place of birth
| Outcome | Primary | Tertiary | Unadjusted OR (95% CI) | p Value (<0.05) | Adjusted OR (95% CI) | p Value |
| Mode of birth | ||||||
| | 318 (77.9%) | 177 (62.3%) | 2.14 (1.53 to 2.99) | <0.0001 | 1.61 (1.08 to 2.39)* |
|
| | 42 (10.3%) | 58 (20.4%) | 0.45 (0.29 to 0.69) | <0.0001 | 0.59 (0.37 to 0.93)* |
|
| Emergency caesarean | 47 (11.6%) | 50 (17.5%) | 0.61 (0.40 to 0.94) | 0.026 | 0.88 (0.55 to 1.40)* | NS |
| Labour onset | ||||||
| | 272 (66.8%) | 140 (49.1%) | 2.09 (1.53 to 2.85) | <0.0001 | 1.94 (1.40 to 2.67)† |
|
| Induction | 59 (14.5%) | 55 (19.3%) | 0.71 (0.47 to 1.06) | NS | 0.77 (0.50 to 1.16)† | NS |
| Elective caesarean | 3 (0.7%) | 6 (2.1%) | 0.34 (0.09 to 1.38) | NS | 0.34 (0.08 to 1.41)† | NS |
| | 70 (17.2%) | 80 (28.2%) | 0.53 (0.37 to 0.76) | 0.001 | 0.54 (0.37 to 0.79)† |
|
|
| 76 (18.7) | 36 (12.6%) | 0.63 (0.41 to 0.97) | <0.05 | 0.54 (0.35 to 0.85)‡ |
|
|
| 303 (75.0) | 182 (65.2) | 0.63 (0.45 to 0.87) | <0.01 | 0.59 (0.42 to 0.84)‡ |
|
| Analgesia | ||||||
| | 85 (20.9%) | 107 (37.5%) | 0.44 (0.31 to 0.62) | <0.0001 | 0.57 (0.38 to 0.85)§ |
|
| Intramuscular/intravenous narcotic | 18 (4.4%) | 23 (8.1%) | 0.52 (0.28 to 0.99) | NS | 0.58 (0.30 to 1.11)§ | NS |
| | 173 (42.4%) | 71 (25.0%) | 2.20 (1.58 to 3.08) | <0.0001 | 2.04 (1.40 to 2.96)§ |
|
| NO2 | 128 (31.4%) | 81 (28.5%) | 1.15 (0.82 to 1.60) | NS | 0.91 (0.64 to 1.29)§ | NS |
| Postpartum haemorrhage | ||||||
| <500 ml | 311 (76.4%) | 215 (75.4%) | 1.05 (0.74 to 1.50) | NS | 0.80 (0.54 to 1.18)* | NS |
| 500–999 ml | 71 (17.4%) | 57 (20.1%) | 0.84 (0.57 to 1.24) | NS | 1.07 (0.70 to 1.61)* | NS |
| >1000 ml | 24 (5.9%) | 13 (4.6%) | 1.30 (0.65 to 2.60) | NS | 1.74 (0.85 to 3.59)* | NS |
| Management of third stage of labour | ||||||
| | 170 (41.8%) | 55 (19.3%) | 3.0 (2.11 to 4.27) | <0.0001 | 2.43 (1.63 to 3.60)§ |
|
| Active | 237 (58.2%) | 230 (80.7%) | ||||
| Perineal trauma | ||||||
| None/graze | 62 (15.2%) | 54 (19.0%) | 0.77 (0.51 to 1.15) | NS | 1.05 (0.68 to 1.64)¶ | NS |
| First/second/labial/vaginal | 200 (49.0%) | 119 (41.9%) | 1.35 (0.99 to 1.83) | NS | 1.20 (0.88 to 1.66)¶ | NS |
| Third/fourth | 9 (2.2%) | 5 (1.8%) | 1.26 (0.42 to 3.80) | NS | 1.43 (0.46 to 4.42)¶ | NS |
| Episiotomy | ||||||
| | 32 (7.8%) | 56 (19.7%) | 0.35 (0.22 to 0.55) | <0.0001 | 0.42 (0.26 to 0.69)¶ |
|
| Extended to third/fourth | 4 (1.0%) | 4 (1.41%) | 0.69 (0.17 to 2.79) | NS | 0.61 (0.13 to 2.85)¶ | NS |
*Adjusted for maternal age, smoking status, parity, term, augmentation, induction.
†Adjusted for maternal age, smoking status, parity, term.
‡Adjusted for maternal age, smoking status, parity, term, augmentation, excludes elective CS.
§Adjusted for maternal age, smoking status, parity, term, augmentation, induction, excludes elective CS.
¶Adjusted for maternal age, smoking status, parity, term, excludes elective CS.
**Statistically significant p values and outcomes are presented in bold.
NS, not significant.
Neonatal clinical outcomes by planned place of birth
| Outcome | Primary | Tertiary | Unadjusted OR (95% CI) | p Value (<0.05) | Adjusted OR (95% CI*) | p Value |
| Apgar score <7 at 5 min | 8 (2.0%) | 6 (2.1%) | 0.93 (0.32 to 2.72) | 0.90 | 0.82 (0.27 to 2.52) | 0.72 |
| Need for resuscitation | ||||||
| Nil | 345 (84.8%) | 234 (82.1%) | NS† | 0.97 (0.63 to 1.50)‡ | NS‡ | |
| Suction | 11 (2.7%) | 9 (3.2%) | ||||
| Supplemental oxygen | 15 (3.7%) | 17 (6.0%) | ||||
| IPP (mask) | 33 (8.1%) | 25 (8.8%) | ||||
| IPP (endotracheal tube) | 3 (0.7%) | 0 | ||||
| Admission to NNU | 24 (5.9%) | 14 (4.9%) | 1.21 (0.61 to 2.37) | NS | 1.44 (0.70 to 2.96) | NS |
| Perinatal outcome | ||||||
| IUD§ or stillbirth¶ | 2 (0.5%) | 0 (0.0%) | †† | NS | †† | |
| Neonatal death** | 1 (0.26%) | 0 (0.0%) | †† | NS | †† | |
| Birth weight (g) | NS | |||||
| <2500 | 7 (1.7%) | 6 (2.1%) | ||||
| 2500–4500 | 386 (95.1%) | 268 (94.7%) | ||||
| >4500 | 13 (3.2%) | 11 (3.5%) | ||||
| Gestational age (completed weeks) | NS | |||||
| <37 | 13 (3.2%) | 11 (6.6%) | ||||
| 37–41 | 379 (93.1%) | 264 (92.6%) | ||||
| 42–43 | 15 (3.7%) | 10 (0.2) | ||||
| Breastfeeding | ||||||
| At birth | 383 (96.7%) | 271 (97.8%) | 0.60 (0.24 to 1.74) | NS | 0.73 (0.26 to 2.01)* | NS |
| Exclusive at 48 hours | 355 (89.2%) | 240 (85.4%) | 1.41 (0.89 to 2.23) | NS | 1.35 (0.84 to 2.20)* | NS |
| Exclusive or fully at 6weeks | 328 (80.6%) | 224 (78.6%) | 1.13 (0.78 to 1.64) | NS | 1.14 (0.76 to 1.70)* | NS |
*Adjusted for maternal age, smoking status, parity, augmentation, induction, term.
†Fisher's exact test for listed proportions of modes of resuscitation.
‡Refers to a dichotomous outcome of ‘resuscitation or not’ adjusted for maternal age, smoking status, parity, augmentation, induction, term.
§Antenatal IUD identified at 38 weeks during routine antenatal visit, baby slightly small for gestational age (SGA), no cause found, no pregnancy complications, well woman.
¶Stillbirth antepartum haemorrhage (APH)/placental abruption at 34 weeks; transfer to TMH and obstetric supervised care at 20 weeks with pregnancy induced hytertension (PIH) ×3 a/n admissions.
**Neonatal death at 3 weeks of age, late onset group B stretococcus (GBS) infection.
††Numbers too small. Multivariate model cannot converge.
IPP, inspiratory positive pressure; IUD, intrauterine death; NNU, neonatal unit (includes neonatal intensive care or special care nursery);